WAPG's MediCity Nottingham based NuVision Biotherapies has come up with a product, which helps to heal eye injuries efficiently and wants to revolutionise the treatment of other wounds. The company recently picked up £1.8 million funding. This is the fourth fundraising round secured by NuVision...
Nottingham experts who designed new eyesight-saving technology are to launch more products which could speed up treatment while reducing the impact on hospital waiting lists and patient visits following COVID-19 restrictions. NuVision which is based at MediCity, Nottingham, has developed the designs from human amniotic membrane...
MediCity, Nottingham based regenerative medicine company has secured a £1.4m investment to fund clinical trials on its new cutting-edge treatment for dry eye disease. The funding for NuVision Biotherapies Ltd comes in part from the MEIF Proof of Concept & Early Stage Fund, which is managed...
Two Nottinghamshire companies are celebrating success following the prestigious Medilink UK Healthcare Business awards, which took place on Wednesday 25th April 2018. The awards recognised a multitude of achievements and outstanding contributions to the Life Sciences, and seven companies from across the country were crowned as...